Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1/2 activation

PLoS One. 2013 Sep 27;8(9):e77027. doi: 10.1371/journal.pone.0077027. eCollection 2013.

Abstract

High concentrations of reactive oxygen species (ROS) induce cellular damage, however at lower concentrations ROS act as intracellular second messengers. In this study, we demonstrate that serotonin (5-HT) transactivates the platelet-derived growth factor (PDGF) type β receptor as well as the TrkB receptor in neuronal cultures and SH-SY5Y cells, and that the transactivation of both receptors is ROS-dependent. Exogenous application of H₂O₂ induced the phosphorylation of these receptors in a dose-dependent fashion, similar to that observed with 5-HT. However the same concentrations of H₂O₂ failed to increase ERK1/2 phosphorylation. Yet, the NADPH oxidase inhibitors diphenyleneiodonium chloride and apocynin blocked both 5-HT-induced PDGFβ receptor phosphorylation and ERK1/2 phosphorylation. The increases in PDGFβ receptor and ERK1/2 phosphorylation were also dependent on protein kinase C activity, likely acting upstream of NADPH oxidase. Additionally, although the ROS scavenger N-acetyl-l-cysteine abrogated 5-HT-induced PDGFβ and TrkB receptor transactivation, it was unable to prevent 5-HT-induced ERK1/2 phosphorylation. Thus, the divergence point for 5-HT-induced receptor tyrosine kinase (RTK) transactivation and ERK1/2 phosphorylation occurs at the level of NADPH oxidase in this system. The ability of 5-HT to induce the production of ROS resulting in transactivation of both PDGFβ and TrkB receptors may suggest that instead of a single GPCR to single RTK pathway, a less selective, more global RTK response to GPCR activation is occurring.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Enzyme Activation / drug effects
  • Humans
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • NADPH Oxidases / metabolism
  • Neurons / enzymology*
  • Phosphorylation / drug effects
  • Reactive Oxygen Species / metabolism*
  • Receptor, Platelet-Derived Growth Factor beta / metabolism*
  • Receptor, trkB / metabolism*
  • Serotonin / pharmacology*
  • Transcriptional Activation / drug effects*

Substances

  • Reactive Oxygen Species
  • Serotonin
  • NADPH Oxidases
  • Receptor, Platelet-Derived Growth Factor beta
  • Receptor, trkB
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3

Grants and funding

This research was funded through generous start-up funding from the University of Waterloo, Faculty of Science, by the National Science and Engineering Research Council of Canada, and by the Queen Elizabeth II Graduate Scholarship in Science and Technology awarded to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.